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Abstract
As the first line of defence, skin is regularly exposed to a variety of biological, physical and
chemical insults. Therefore, determining the skin sensitization potential of new chemicals is of
paramount importance from the safety assessment and regulatory point of view. Given the
questionable biological relevance of animal models to human as well as ethical and regulatory
pressure to limit or stop the use of animal models for safety testing, there is a need for
developing simple yet physiologically relevant models of human skin. Herein, we describe the
construction of a novel immunocompetent 3D human skin model comprising of dendritic cells
co-cultured with keratinocytes and fibroblasts. This model culture system is simple to
assemble with readily-available components and importantly, can be separated into its
constitutive individual layers to allow further insight into cell–cell interactions and detailed
studies of the mechanisms of skin sensitization. In this study, using non-degradable microfibre
scaffolds and a cell-laden gel, we have engineered a multilayer 3D immunocompetent model
comprised of keratinocytes and fibroblasts that are interspersed with dendritic cells. We have
characterized this model using a combination of confocal microscopy, immuno-histochemistry
and scanning electron microscopy and have shown differentiation of the epidermal layer and
formation of an epidermal barrier. Crucially the immune cells in the model are able to migrate
and remain responsive to stimulation with skin sensitizers even at low concentrations.
We therefore suggest this new biologically relevant skin model will prove valuable in
investigating the mechanisms of allergic contact dermatitis and other skin pathologies in
human. Once fully optimized, this model can also be used as a platform for testing the
allergenic potential of new chemicals and drug leads.
(Some figures may appear in colour only in the online journal)
3 Contributed equally to the work and should be considered joint first authors.
4 Authors to whom any correspondence should be addressed.
Content from this work may be used under the terms of
the Creative Commons Attribution 3.0 licence. Any further
distribution of this work must maintain attribution to the author(s) and the
title of the work, journal citation and DOI.
1. Introduction
The primary focus of tissue engineering approaches has
been repair, replacement and/or regeneration of damaged
or diseased tissue by the exploitation of cells, biomaterials
and specific growth factors. Such applications have gained
significant momentum over the years due to the intense demand
for tissues substitutes. However, the need for using biologically
relevant tissue constructs as alternatives to animal models
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for drug development and/or disease modelling has furthered
interests within the field (Ghaemmaghami et al 2012, Elliott
and Yuan 2011, Haycock 2011, Langer and Vacanti 1993).
Skin is one of body’s first defence barriers and consists of
an outer epidermal layer of keratinocytes and a lower dermal
layer of fibroblasts, interspersed with a family of dendritic cells
(DCs) which contribute to regulating the immune response
of the skin (see reviews by Metcalfe and Ferguson 2007,
Callard and Harper 2007, Ryan et al 2007). Ever since the
seminal work of Rheinwald and Green (1975), a variety of
skin substitutes have been developed over the years that include
both acellular and cellular alternatives and, to this end, several
commercial products have been available for use in the clinic
(reviewed in Shevchenko et al (2010)). Moreover, several
models also exist which replicate diseased states and/or mimic
the dermal physiological environment e.g. wound healing,
diabetes, skin contraction, pigmentation and tumour invasion
(Groeber et al 2011, Lammers et al 2011, Brohem et al 2011,
MacNeil 2007, Harrison et al 2006).
We are increasingly exposed to a variety of new chemicals
that are used in personal and healthcare products. The potential
toxicity of any chemical is always a cause of concern but
their ability to elicit adverse dermal allergenic/immunogenic
responses also needs to be considered. Historically, such
concerns have led to the development of numerous
test-methods including the guinea pig maximization test
(Magnusson and Kligman 1969), the Buehler test (Robinson
et al 1990) and the local lymph node assay in its
original and modified versions (Hilton and Kimber 1995,
Kimber et al 1995, 2001). Whilst informative and still in
current use (under the implementation of the Registration,
Evaluation, Authorisation and Restriction of Chemicals
(REACH) 1907/2006 regulation (Adler et al 2011)), the
majority of these models suffer from several limitations
including their questionable biological relevance to humans.
Moreover, it is expected that the use of animal models in
safety testing will be significantly limited due to introduction
of the 7th Amendment to the EU Cosmetics Directive.
Therefore, there is an urgent need to establish more reliable
and physiologically relevant models for the assessment of
substances that may cause skin sensitization and also address
the ethical aspects of animal testing. Whilst a number of
human skin model equivalents exist and have been successfully
used for skin ‘irritation’ studies, there are very few skin
models, which are ‘immunocompetent’ and hence suitable
for performing skin ‘sensitization’ studies (Reuter et al 2011,
Johansson et al 2012, Pistoor et al 1996, LeClaire and de
Silva 1998, Streilein 1989). With only a limited number of
models currently available and to close the clear gap in the
growing pool of in vitro sensitization methods, our aim was
to develop a physiologically relevant human based 3D model
of keratinocytes, DCs and fibroblasts which can be readily
assembled and, importantly, be separated into its constitutive
individual layers to allow further elucidation of cell–cell
interactions and detailed studies of the mechanisms of skin
sensitization. Not only can this model be used for the testing of
the allergenic potential of novel chemicals but can also provide
valuable insight to the molecular basis of skin sensitization.
2. Materials and methods
2.1. Ethics approval
The isolation of human epidermal keratinocytes and human
dermal fibroblasts was performed from skin samples obtained,
with prior written consent, from female patients undergoing
surgery for breast reductions or abdominoplasty. The
procedure was approved by the local ethics committee
(Sheffield NHS Trust, Sheffield, UK) and samples were
handled and stored under The Human Tissue Authority (UK)
license number 12179. Peripheral blood of healthy volunteers
was used for the generation of monocyte-derived DCs which
was obtained with prior written consent and the approval of
the University of Nottingham Medical School Research Ethics
Committee.
2.2. Scaffold generation
A commercially available microfibre-based construct (i.e. SLS
SelectwipesTM, SLS, Nottingham, UK), made of wet spun
PES/viscose rayon microfibre material containing a butadiene
copolymer, was used as the cell scaffold support throughout
this study. These scaffolds were cut into 2 cm diameter circles
(200 μm thickness) and stored in 70% (v/v) IPA before use.
Prior to surface modification, scaffolds were washed thrice
in sterile PBS before air-drying on 90 mm petri dishes in a
microbiological safety cabinet. For the plasma polymerization
process, an in-house developed radio frequency (RF) plasma
polymer deposition reactor consisting of a glass cylindrical
tube (L: 40 cm; ∅: 10 cm) enclosed within a copper
coiled element and closed by aluminium/brass endplates
(QVF, Stafford, UK) was used. Briefly, operating conditions
consisted of a base and working pressure of 3 × 10−3 mbar
and 6 × 10−3 mbar respectively to ensure a steady acrylic
acid flow rate of 2.4–2.5 cm3 min–1 throughout the system.
Acrylic acid (147230, Sigma-Aldrich, Poole, UK) plasma
formation was initiated and sustained at 13.56 MHz (15 W
discharge power) using a RF signal generator (Coaxial Power
Systems Ltd, Eastbourne, UK) and the process terminated
following a 10 min coating cycle. Impedance matching was
used throughout the process to ensure that the reflected RF
power was minimized.
2.3. Isolation of keratinocytes and fibroblasts from donor skin
The isolation of dermal fibroblasts and epidermal keratinocytes
from freshly acquired skin was performed as previously
described (Ralston et al 1999, Goberdhan et al 1993). Briefly,
skin samples were cut into 0.5 cm2 pieces and left overnight
at 4 ◦C in Difco-trypsin (0.1% (w/v) trypsin, 0.1% (w/v)
D-glucose in PBS, pH 7.45) before being washed and
maintained in PBS. The epidermis was excised before the
papillary surface of the dermis was gently scraped to remove
basal keratinocytes, harvested by centrifugation (200 g for
5 min) and then resuspended in Green’s medium (Canto`n
et al 2010, Haddow et al 1999). Subsequently, keratinocytes
were seeded (1 × 106 cells cm–2) into 75 cm2 tissue culture
flasks containing a feeder layer of irradiated mouse 3T3 cells
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and incubated in a humidified incubator (37 ◦C and 5% (v/v)
CO2) until reaching 80–90% confluency. For 3D cultures,
keratinocytes were used between passages 1 and 2. Fibroblast
isolation was achieved by mincing the dermis with a scalpel
blade into 5–10 mm2 pieces before incubating them overnight
at 37 ◦C in a solution of 0.5% (w/v) collagenase A. The
suspension of fibroblasts that remained was collected via
centrifugation (400 g for 10 min) and resuspended in DMEM
containing 10% (v/v) FBS, 100 IU ml–1 penicillin, 100 mg
ml–1 streptomycin, 2 mM L-glutamine and 0.625 μg ml−1
amphotericin B. Cells were seeded into a 25 cm2 tissue
culture flask and cultured in a humidified incubator (37 ◦C
and 5% (v/v) CO2) until 80–90% confluent. For 3D cultures,
fibroblasts were used between passages 4 and 7.
2.4. Purifying monocytes and generation of monocyte derived
dendritic cells (mDCs)
mDCs were generated from peripheral blood monocytes
(PBMC) of healthy volunteers as previously described
(Horlock et al 2007). Briefly, PBMC were separated
from heparinized whole blood by a standard density
gradient centrifugation protocol using Histopaque R©1077
(Sigma, Poole, UK). Monocytes were purified using the
MACSTM anti-CD14 microbead separation kit (Miltenyi
Biotec, Woking, UK). Generation of immature DCs consisted
of culturing 1 × 106 CD14+ cells (with >90% purity) in 1 ml
RPMI medium supplemented with 10% (v/v) FCS, 2mM
L-glutamine and 1% (v/v) penicillin–streptomycin solution,
250 U ml–1 recombinant human (rh) IL-4 and 50 ng ml–1 (rh)
GM-CSF (R&D Systems, Oxford, UK), for six days, in a 12-
well plate (Corning, CA).
2.5. Immune layer: mDCs incorporated agarose–fibronectin
gel
mDCs were incorporated within an agarose–fibronectin gel
and this whole construct formed the ‘immune layer’ of the
3D model. Briefly, a 4% (w/v) agarose solution (Sigma-
Aldrich, Poole, UK) was heated in a water-bath at 80 ◦C until
completely solubilized. 450 μl of this molten agarose was
then transferred to a well (24 well-plate) and allowed to cool
<37 ◦C before 50 μl of 0.1% (w/v) fibronectin solution (from
human plasma, Sigma-Aldrich) was added directly to the well
and mixed thoroughly by pulsing the pipette tip. Immediately
thereafter, 25–50 μl of mDCs cell suspension was added to the
centre of the agarose–fibronectin gel and the whole construct
transferred to a humidified incubator (at 37 ◦C and 5% CO2)
for 30 min to allow the gel to set. Following this incubation,
300 μl of complete media was added to the well and the plate
returned to the incubator for a further 90 min before the centre
of the cells-in-gel was removed/cut-to-size using a standard
sized cork-borer (Size 4, Sigma-Aldrich, Poole, UK) and used
immediately thereafter.
2.6. Construction of a 3D co-culture model
Keratinocytes (5 × 105) were seeded onto a four-layer thick
stack of acrylic acid pre-treated microfibre scaffolds, contained
within a stainless steel ring (∅: 1 cm), and cultured for two
days in Green’s medium. In parallel, fibroblasts (1.5 × 105)
were seeded on a four-layer thick stack of untreated scaffolds,
within a stainless steel ring (∅: 1 cm), and cultured for two
days in complete DMEM. Following two days of culture
in a humidified incubator at 37 ◦C and 5% (v/v) CO2, the
metal rings were removed and the top layer of each cell line
specific scaffold stack were combined using CellCrownTM
inserts ensuring that fibroblasts were placed at the bottom, a
4% (w/v) agarose gel insert (∅: 1.2 cm) in the middle and the
keratinocyte layer at the top. This construct was then placed
into a six well-plate and complete medium added to ensure
that the upper (keratinocyte) layer was at the air–liquid (A–L)
interface and cultured for a total of six days. The initial five
days was in complete Green’s medium followed by one day in
Green’s medium without hydrocortisone (HC) or cholera toxin
(CT). Following this culture period, the 4% (w/v) agarose
gel was removed and replaced with the mDCs incorporated
fibronectin–agarose gel insert as described above and cultured
in a (50:50) mixture of Green’s medium (without HC and CT):
RPMI medium (supplemented with 10% (v/v) FBS, 2 mM
L-glutamine and 1% (v/v) penicillin–streptomycin solution)
and kept in a humidified incubator at 37 ◦C and 5% (v/v)
CO2, overnight, prior to immediate use. The number of cells
of each population was pre-defined at a ratio of (30:10:1) for
the (keratinocyte:fibroblast:mDCs) for the complete 3D cell
model set-up. To ensure that differentiation was permissible,
the construct was placed on a plastic support in order to
maintain culture at an A–L interface (figure 1).
2.7. Scanning electron microscopy (SEM)
Scaffold layers from the 3D cell model were fixed in 3.7%
(w/v) glutaraldehyde (in 0.1M PBS) for 4 h at 4 ◦C, washed
twice (15 min intervals) with cold 0.1 M PBS and then treated
with 2% (v/v) osmium tetraoxide solution for 1 h. Following
this fixation step, samples were washed twice with cold 0.1 M
PBS and then processed through a series of 15 min dehydration
steps involving ethanol (50%, 75%, 95% and 100%) before
being left to air-dry over anhydrous copper sulfate for 15 min.
Samples were then placed in a (50:50) mixture of (100%
hexamethyldisiazane:100% ethanol) for 30 min followed by
another 30 min in 100% hexamethyldisiazane before being left
to air-dry overnight. Specimens were thereafter mounted on
12.5 mm aluminium SEM stubs using double-sided sticky tabs
and then gold coated (25 nm layer), under an argon atmosphere,
in an Edwards S150B sputter-coater. Coated samples were
examined using a Philips XL-20 SEM unit operating at an
accelerating voltage of 20 kV.
2.8. Immunostaining of layers for imaging
Following a one-week culture at an A–L interface, the 3D
constructs were fixed in 3.7% (v/v) formaldehyde before being
washed thrice with PBS. The construct was then dismantled
and both the upper (keratinocytes) and bottom (fibroblasts)
layers were permeabilized using 1% (v/v) Triton-X100, 1 h
at 4 ◦C, before being washed thrice again with PBS. For the
keratinocytes, the layer was pre-blocked with 5% (w/v) BSA
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Figure 1. Schematic of the complete 3D co-culture model. 500 K keratinocytes, 150 K fibroblasts and 15 K mDCs were pre-seeded onto
the appropriate scaffolds/matrix before being assembled together using CellCrownTM inserts—ensuring that the agarose gel was sandwiched
between the upper (keratinocyte) and bottom (fibroblast) layers. This entire construct was then placed onto a plastic platform insert
(blue square) with sufficient medium added to each well to ensure an A–L interface was maintained throughout the culture period.
(in PBS) for 1h, at room temperature, followed by three washes
with PBS and then incubated with cytokeratin pan AE1/AE3
mouse monoclonal antibody (1:50 with 1% (w/v) BSA in
PBS) (GTX73583, Source Bioscience, UK) overnight, at 4 ◦C.
Following this incubation, the sample was washed thrice with
PBS and then incubated with a biotinylated goat anti-mouse
secondary antibody (1:500 with 1% (w/v) BSA in PBS) (BA
9200, Vector Laboratories, UK) for 1 h, at room temperature,
before being washed as above. Finally, fluorescein streptavidin
(1:100 with 1% (w/v) BSA in PBS) (SA 5001, Vector
Laboratories, UK) was added to the layer and incubated for
30 min, at room temperature, and washed again. For both
layers, an additional staining with phalloidin-TRITC (1:250)
(P1951, Sigma-Aldrich, UK) and DAPI (1:1000) (D9542,
Sigma-Aldrich, UK) in PBS were performed and incubated for
1 h, at room temperature, followed by three washes with PBS.
All the samples were imaged, in PBS, using a 40 × water-
dipping lens on a Zeiss LSM510 META confocal microscope.
2.9. Histology and immunohistochemistry
3D models were fixed in 3.7% (v/v) formaldehyde,
dehydrated, cleared and infiltrated with molten paraffin wax
using a Leica 1020 Tissue Processor. Initial experiments were
performed using cryosectioning but fracturing of the scaffold
fibres was found to introduce artefacts to the sections and cause
physical disruption to the organized structure. Briefly, samples
were then cut vertically in half and embedded in paraffin wax so
that sectioning was perpendicular to the surface of the sample.
Sections (8 μm) were mounted on Superfrost glass microscope
slides, allowed to air-dry overnight, de-waxed and rehydrated
(xylene and 100%, 90% and 70% (v/v) graded alcohol in tap
water) before staining with haematoxylin and eosin (H&E).
Stained samples were dehydrated and mounted with DPX
mounting medium before imaging. For visualizing specific
proteins within the 3D model, the following antibodies were
used: mouse monoclonal Ki67 antigen (NCL-L-Ki67-MM1,
NovocastraTM, Leica Microsystems, UK), mouse monoclonal
to Involucrin, clone SY5 (NCL-INV, NovocastraTM, Leica
Microsystems, UK), mouse monoclonal to Cytokeratin pan
(AE1/AE3) antibody (GTX73583, Source Bioscience, UK),
mouse monoclonal (DE-K10) to cytokeratin-10 (ab9026,
Abcam, UK) and mouse monoclonal (LL002) to cytokeratin-
14 (ab7800, Abcam, UK). Immunohistochemical staining was
carried out on tissue sections using Vectastain Elite ABC kit
(PK-6100, Vector Laboratories, UK).
2.10. Electrical skin impedance determination
The barrier properties of the 3D constructs were assessed
using a NOVA Technologies DPM9003 electrode (NOVA
Technologies Corporation, LA, USA) to directly measure skin
impedance/relative hydration. Impedance for each sample was
measured following an initial 5 s steady state contact time with
the sample. Values were compared and normalized against a
sample of tissue-engineered skin (fibroblasts and keratinocytes
seeded onto the papillary surface of de-epidermalized dermis
and cultured at the A–L interface in Green’s medium)
(Smith et al 2010, Chakrabarty et al 1999).
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2.11. Total collagen deposition within individual scaffold
layers
The 3D co-culture model was cultured for one week at an A–L
interface (37 ◦C and 5% CO2) and then fixed in 3.7% (v/v)
formaldehyde. After separating the layers, samples were
washed thrice in PBS and then incubated for 18 h at room
temperature with 0.1% (w/v) Sirius Red in picric acid. Each
layer was then washed thoroughly using tap water and air-dried
before taking photographs.
2.12. Stimulating the 3D co-culture model
An established skin sensitizer, dinitrochlorobenzene (DNCB),
at 2 μM was used to stimulate this model for 24 h (Kuper
et al 2008). In short, 20 μl of the DNCB solution was
directly added to the upper layer (keratinocytes) of the model
and then left in a humidified incubator at 37 ◦C and 5%
(v/v) CO2. Following 24 h of incubation, the model was
then separated into its individual layers: the agarose gel
transferred to a bijoux containing RPMI for DC retrieval
and phenotyping while the scaffold layers analysed for cell
viability using a standard MTT assay according to the
manufacturer’s instructions (0.5 mg ml−1 MTT in PBS,
45 min at 37 ◦C) and/or immunohistochemistry/confocal
imaging/microscopy. Supernatants from the culture constructs
were also collected, centrifuged (to collect migrated DCs)
before being frozen (−20 ◦C) immediately for cytokine
analysis at a later date. The cell pellet was resuspended in
complete RPMI medium in preparation for flow cytometry
analysis.
2.13. Recovering mDCs from agarose–fibronectin gel layer
DCs were retrieved from the agarose–fibronectin gel using
a combination of mild mechanical homogenization and
straining/sieving. Briefly, gel samples were removed from the
well plate/experimental set-up and placed in a GentleMACS
C-tube (Miltenyi Biotec, Woking, UK) with 15 ml of PBS.
Tubes were then processed using the pre-loaded programmes
on the GentleMACS Dissociator namely, a four-step cycle of
‘spleen_01, lung_01, heart_01 and spleen_01’ prior to being
centrifuged, at 350 g for 5 min, to collect any cells/debris
dispersed at the base of the cap or around the impeller of the
C-tube. Following centrifugation, the supernatant was
removed and the pellet resuspended in 20 ml of PBS. This
mixture was then passed through a 100 μm BD Falcon cell
strainer (BD Biosciences, Oxford, UK) into a 50 ml Falcon
tube to remove the larger sized debris. The cell strainer was
then washed with a further 20 ml of PBS before the sample
centrifuged at 350 g for 5 min. Again, the supernatant was
removed and the resuspended pellet (20 ml of PBS) passed
through a 70 μm BD Falcon cell strainer and washed as above.
The remaining cell pellet was then collected by centrifugation
at 350 g for another 5 min. If samples were to be processed for
FACS analysis, an additional step using a 40 μm BD Falcon
cell strainer was performed.
2.14. Flow cytometry for expression of cell surface markers
Expression of cell surface markers was assessed by the addition
of monoclonal antibodies with specificity for individual cell
surface markers. All antibodies and isotype controls were
purchased from Beckman Coulter (High Wycombe, UK)
unless otherwise stated. The panel of antibodies used in this
investigation include: PE-CD11c (clone BU15, IgG1), FITC-
CD14 (clone RMO52, IgG2a), FITC-CD54 (clone 84H10,
IgG1), FITC-CD80 (clone MAB104, IgG1), PCy5-CD83
(clone HB15a, IgG2b), PE-CD86 (clone HA5.2B7, IgG2bκ),
DEC205 (clone MG38, IgG2b, AbD Serotec), PE-CD206
(clone 3.29B1.10, IgG1), PE-CD209 (clone AZND1, IgG1),
PCy5-HLA-DR (Immu-357, IgG1), FITC-CD324 (clone
67A4, IgG1, BioLegend) and FITC-Annexin V (clone VA33,
IgG2a, AbD Serotec). Additionally, an unstained sample and
the appropriate isotype control were included in each batch
analysis to address autofluorescence and non-specific binding,
respectively.
Cells were harvested and washed twice with PBA (0.5%
(w/v) BSA and 0.1% (w/v) sodium azide in PBS). Following
the final wash, the supernatant was removed and 5 μl of each of
the antibodies of interest were added to the resultant cell pellet
(residual volume ∼50 μl) before being vortexed and incubated,
in the dark, for 20 min at 4 ◦C. Following incubation, the
sample was washed with PBA before the addition of 600 μl
of fixing solution (0.5% (v/v) formaldehyde, in PBS) and
stored in the dark, at 4 ◦C, for a maximum of seven days.
Acquisition was achieved using a Beckman Coulter EPICS
AltraTM flow cytometer (Beckman Coulter, High Wycombe,
UK) with a minimum of 8000 events collected for each
sample. Data was analysed thereafter using WinMDI 2.9
software (build #2, 6-19-2000; Scripps Research Institute.
http://facs.scripps.edu/software.html). Viable DCs were gated
based on cells forward and side scatter characteristics as well as
the expression of a lineage marker (i.e. CD11c). The absolute
mean fluorescence intensity (MFI) value for each marker was
determined. Absolute MFI value is defined as: [absolute MFI]
= [MFI value of sample] – [MFI value of isotype/unstained
sample].
2.15. Cytokine expression
Cytokine production by cells was quantified using the Human
IL-1α, IL-6 and IL-8 ELISA kits (Peprotech, London, UK)
according to the manufacturer’s instructions. Detection was
achieved using a BioTek ELx800 plate reader (Potton,
Bedfordshire, UK) operating at 405 nm (630 nm correction)
and normalized against the standard blank controls.
2.16. Investigation of the influence of keratinocyte
differentiation on the response to SDS
Normal human keratinocytes were seeded on tissue culture
plastic and cultured in Green’s medium (10% FCS, 1.8 mM
CaCl2) at 37 ◦C and 5% CO2. Keratinocytes were either
cultured to 80–90% confluency so that the cells were largely
proliferative or for 3–5 days to achieve post-100% confluency
and inducing differentiation. In both conditions, keratinocytes
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Table 1. Composition of selected media formulations and its interaction with monocyte-derived dendritic cells.
g L–1
RPMI DMEM Ham’s F12 Greens Co-culture
Component/media (R0883) (41965039) (21765029) (3 × DMEM:1 × F12) (RPMI:Greens)
Others
D-glucose 2.0 4.5 1.8 3.8 2.9
Supplements
FCS/FBS (% v/v) 10 10 – 10 10
L-glutamine (mM) 2 2 – 2 2
Penicillin (ILU ml–1) 100 100 – 100 100
Streptomycin (μg ml–1) 100 100 – 100 100
Amphotericin B (μg ml–1) – 0.62 – 0.62 0.31
Epidermal growth factor (ng ml–1) – – – 10 5
Hydrocortisone (μg ml–1) – – – 0.4 –
Cholera toxin (mol L–1) 1 × 10−10 –
Adenine (mol L–1) 1.8 × 10−4 0.9 × 10−4
Insulin (μg ml–1) – – – 5 2.5
Transferrin (μg ml–1) 5 2.5
Triiodothyrionine (mol L–1) – – – 2 × 10−8 1 × 10−8
Greens Co-culture
With Without With Without
mDCs characterization (n = 5) RPMI DMEM Ham’s F12 HC/CT HC/CT HC/CT HC/CT
% Cell viability (trypan blue exclusion assay) 99 ± 3.72 – – 96 ± 2.61 98 ± 2.82 99 ± 3.81 99 ± 4.01
Cell surface marker 84.56 (CD86) – – 87.84 142.02 82.18 117.08
Expression level 190.88 (CD54) – – 45.61 117.71 71.83 115.42
Absolute MFI valuea 585.44 (CD11c) – – 407.18 10.38 526.04 771.80
Endocytosis uptake level (MFI)b 27.32 – – 23.50 3.52 26.49 23.69
a Absolute MFI value = (MFI of sample) – (MFI isotype/unstained sample) based on representative sample.
b MFI = (MFI of sample at 37 ◦C) – (MFI of sample at 4 ◦C) based on representative sample.
MFI = mean fluorescence intensity, HC = hydrocortisone, CT = cholera toxin, mDCs = monocyte-derived dendritic cell.
were washed three times with serum-free DMEM (sfDMEM)
and then incubated with 10−4 M SDS (in sfDMEM) for 24 h.
sfDMEM was used as the negative control. Following 24 h
incubation, the medium was collected and immediately frozen
for subsequent analysis of IL-1α expression by ELISA. The
cells were incubated in lysis buffer (48% urea, 5% SDS) for 1 h
at 37 ◦C and then immediately frozen. A BCA protein assay
was performed according to the manufacturer’s instructions to
quantify the total protein content of the cell lysate.
2.17. Statistical analysis
Mean values and standard deviations were calculated for each
sample and the differences between the means were compared
using Student’s t-test (two-tailed) or one-way ANOVA where
appropriate with p < 0.05 considered as significant. Microsoft
Excel 2007 and/or SigmaPlot (Stat) software were used to
perform the analysis.
3. Results
3.1. Establishing a media for cell co-culture
Initial work focused on defining a mutually compatible media
in which keratinocytes and fibroblasts could be maintained
following their individual expansion. In contrast, the challenge
for mDCs co-culture was to prevent their constitutive
maturation. Thus, a number of media combinations were
investigated and it was found that a mixture of RPMI and
Greens media was optimal as summarized in table 1. The
selected media composition not only supported the growth
and differentiation of all three cell-types but did not induce any
detrimental impact on cell viability, phenotype and function.
3.2. Construction of the multi-layered model
The isolation and routine culture of individual populations of
primary keratinocytes and fibroblasts on acrylic acid coated
microfibre-based scaffolds was achieved. Importantly, these
cells were able to lay down their own ECM, which can
be seen to intercalate and/or coat the pores of the scaffold
construct within seven days of culture. Figures 2(A)–(B) show
by SEM, a high resolution three-dimensional observation of
the top surface and transverse edge of keratinocytes cultured
on the scaffolds. Samples produced a stratum of ∼100 μm
thickness within seven days and the cells appeared to populate
the scaffold throughout. In contrast, the fibroblast layer only
reached a thickness of ∼30 μm and the cells remain localized
on the surface of the construct even following 14 days of
culture (data not shown).
mDCs were successfully incorporated within a 4%
agarose–fibronectin gel layer. CD11c, CD54, CD83, CD86,
and HLA-DR expression and the ability to uptake FITC-
dextran (i.e. endocytosis) confirmed that the cells maintained
6
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Figure 2. (A) Aerial view. (B) Lateral view scanning electron microscopy (SEM) images of individual layers of microfibre-based scaffolds
with or without keratinocytes/fibroblasts. Cells were seeded and cultured (A–L interface; at 37 ◦C and 5% (v/v) CO2) on the appropriate
scaffolds for seven days before being fixed, 1% osmium tetraoxide treated and mounted onto SEM stubs. Samples were gold coated
(25 nm layer) before being examined using a Philips XL-20 SEM unit operating at an accelerating voltage of 20 kV and at the corresponding
magnifications. Red arrows correspond to areas of fibroblast and keratinocyte localization.
their immature phenotype and functionality throughout the
culture period within this matrix following their recovery as
described in section 2 (data not shown). Importantly, the mDCs
were homogenously distributed within the matrix and time-
lapse imaging demonstrated that they were viable and able to
migrate both vertically and horizontally for up to five days
(figure 3). On day 5, the majority of mDCs had migrated from
the agarose layer and appeared in the supernatant. Cells in the
supernatant maintained greater than 90% viability (data not
shown).
Thus, 3D models consisting of keratinocytes and
fibroblasts, with or without an agarose–fibronectin gel layer
insert, were constructed and used to assess structural integrity
and barrier formation. Histological assessment of sectioned
samples (8 μm) was achieved using H&E staining followed
by specific staining for proliferation markers and key dermal
structural proteins such as Ki67, involucrin, pancytokeratin,
cytokeratin-10 and cytokeratin-14. It is important to note that
keratinocytes were contained within a microfibre scaffold,
the fibres of which were dissolved by the solvents used
in standard histological processing. This resulted in an
atypical appearance of ‘ghosting’ observed for H&E and
immunolabelled histology. With this in mind, it can be seen
that although both model constructs (i.e. with or without
agarose–fibronectin gel) demonstrated positive staining for all
aforementioned markers, with the keratinocyte organization
more evident in samples where the agarose–fibronectin
gel layer was present during the seven-day culture period
(figures 4(A)–(D)). At this time point, Ki67 was expressed by
the nuclei of basal keratinocytes, with a negative expression
7
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Figure 3. Incorporation and migration of mDCs within 4% agarose–fibronectin gel insert. Confirmation of the mDCs incorporation within
the gel was achieved using standard histology techniques as described in section 2: the 8 μm section stained using 0.25% (w/v)
May-Grunwald (in methanol) and 0.4% (w/v) Giemsa stains (in methanol) prior to imaging with a Nikon SM21500 microscope. (A) mDCs
can be seen as small dark spots within the gel matrix (red arrow) with the (insert) depicting an aerial view of the gel matrix under ×10
magnification. (B(i)–(vi)) Composite numbered images derived from a brightfield time-lapse movie of mDCs incorporated within the 4%
agarose gel and cultured for five days at 37 ◦C and 5% (v/v) CO2. Images document horizontal movement of specific mDCs (within red
circle) and vertical movement (ghosting of cell, i.e. moving in/out of focus) from the region of interest. Each panel is corresponds to ∼24 h
time point.
in keratinocytes in the upper layers. However, by day 14 no
expression of Ki67 was observed in any of the keratinocyte
layers. Similarly, the differentiation marker cytokeratin-10 was
observed at day 7 in the uppermost layer of keratinocytes with
negative staining in the basal layers, but by day 14 uniform
expression across basal and upper layers was observed.
Cytokeratin-14, a basal epithelial cell marker, was expressed at
day 7 by more basally-located keratinocytes, whereas by day
14 little expression was seen. Thus, keratinocytes appeared to
have terminally differentiated by day 14 and in the presence
of the agarose–fibronectin gel layer, the presence of which
appeared to support better epithelial formation.
Confocal and brightfield microscopy were used to
assess barrier formation and samples were compared against
8
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Figure 4. Histological analyses of epidermal layer following culture with and without the agarose–fibronectin gel layer insert. Samples were
cultured for one week and two weeks at an A–L interface (at 37 ◦C and 5% (v/v) CO2) before being processed (8 μm sections) using
standard IHC staining protocols as described in section 2. (A) Control samples with no 4% agarose–fibronectin gel layer; (B) Samples with
4% agarose–fibronectin gel layer—1 week; (C) Sample with 4% agarose–fibronectin gel layer—2 weeks; (D) High magnification of markers
for samples grown in 4% agarose–fibronectin at 1 and 2 weeks.
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200µM 200µM
Figure 5. Structural integrity of 3D cell model construct. (A) Confocal and H&E histology was used to assess the structural integrity of the
3D co-culture model following a seven-day culture period (A–L interface; at 37 ◦C and 5% (v/v) CO2). For histology, tissue-engineered skin
was used based on human allodermis. 8 μm section samples were stained using pancytokeratin (green) and DAPI (blue) before being
viewed using a Zeiss LSM510 META confocal microscope or, H&E stained and viewed using a Leica DM-IRB brightfield microscope.
Reconstructed Z-stack confocal images of the 3D model scaffolds with (B) upper layer of keratinocytes stained with pancytokeratin (green)
and DAPI (blue), and (C) bottom layer of fibroblasts stained for phalloidin-TRITC (red) and DAPI (blue)
(A) (B) (C )
Figure 6. Total collagen deposition within individual scaffold layers/cell populations. Samples were cultured for one week (A–L interface;
at 37 ◦C and 5% (v/v) CO2) before being dismantled and then stained using 0.1% (w/v) Sirius Red in picric acid (18 h, room temperature).
Images representative of three independent sample model constructs.
tissue-engineered skin (see section 2) (Chakrabarty et al
1999, Smith et al 2010). Z-stack reconstruction of 3D model
with agarose–fibronectin gel was made, which demonstrated
properties of epithelial organization. This was evident by a
complete coverage of the upper scaffold when labelled
for pancytokeratin, which was expressed further and
inter-dispersed by more deeply located keratinocytes
(figures 5(A)–(B)). On the bottom scaffold, the presence of
fibroblasts within a dense network of actin fibres was seen
(figure 5(C)). Collagen production by the keratinocytes (with
a confirmed viability assessment) was maintained following
culture within the 3D co-culture construct as evidenced by
picosirius red positive staining. In addition the method used
would identify ECM proteins, plus intermediate filament
proteins such as keratin, and hence the strong positive stain
from the top layer containing keratinocytes is of note (figure 6).
Barrier formation and integrity were further characterized
using transepithelial impedance measurements (figure 7).
Samples were investigated under wet and dry conditions. The
impedance technique relies on the presence of water and a
major difference was observed between all four samples when
measured wet versus dry. The highest wet impedance data
were recorded for TE skin and the 3D model. Interestingly,
donor skin gave a lower value to that of these samples and was
similar to that of the wet scaffold alone. We conclude that this
was due to the TE skin and 3D model samples being ‘alive’ and
able to actively maintain a barrier. The donor skin in contrast
was an excised sample and the time between retrieval and
analysis was 24 h. Consequently the cellular integrity would
have started to decline. On the basis of these results, the seven-
day culture period sample (at an A–L interface) was selected
for functional stimulation studies.
3.3. Model stimulation and cell migration
Stimulation of the complete 3D co-culture model was achieved
using 2 μM DNCB which was delivered by the direct addition
to the top layer of the construct (keratinocytes) in a 20 μl
10
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Table 2. Summary of the number of mDCs present in the scaffold layers following stimulation with 2 and 10 μM DNCB for 24 h
(37 ◦C and 5% CO2). Sample images were selected from a random field of vision and viewed using confocal microscopy. Control = no
treatment; (T) = top layer; (B) = bottom layer.
Control Control DMSO DMSO 2 μM 2 μM 10 μM 10 μM
(T) (B) (T) (B) DNCB (T) DNCB (B) DNCB (T) DNCB (B)
Number of cells 3 5 1 2 0 14 1 14
Number of images 5 4 3 3 3 6 3 5
Av. number of cells/0.21 mm2 0.6 1.25 0.33 0.67 0 2.3 0.33 2.8
Figure 7. Transepithelial skin impedance. Electrical impedance
measurements for human donor skin, tissue engineered skin
(i.e. de-epidermalized dermis incorporating keratinocytes and
fibroblasts), a cell-free scaffold and the 3D model construct were
assessed under wet and dry conditions using a Nova Technologies
DPM9003 electrode according to the manufacturer’s instructions.
Measurements were taken after a steady state reading was achieved
(10 s) following initial electrode contact and results are the mean
values ± SD from three independent experiments.
volume. Following stimulation, parallel samples of the model
were processed for imaging (to study cell migration) and the
recovered mDCs (from both the supernatant and agarose–
fibronectin gel layer) were subjected to phenotype and
cytokine expression (ELISA-based) analyses. Movement of
the mDCs into the scaffold layers was characterized by live
cell fluorescence imaging (confocal microscopy) (figure 8).
The number of labelled cells, within five random fields of
vision was assessed following 24 h stimulation with 2 μM or
10 μM DNCB (table 2). It was observed that mDCs migration
between the scaffold layers occurred for all sample conditions
but, following stimulation with DNCB, a greater number of
mDCs moved towards the bottom scaffold (i.e. fibroblast
layer) in agreement with observations reported in the literature
(Ouwehand et al 2008, 2010).
3.4. Cytokine production in response to DNCB in 2D and 3D
model
Expression of IL-1α, IL-6 and IL-8 were measured by ELISA
in the 3D model following addition of 2 μM DNCB to the
upper epithelial surface for 24 h. A standard irritant (10−4M
SDS) was also included in the experiment for comparison.
No significant differences were observed for either DNCB
or SDS-stimulated samples versus the un-stimulated or
DMSO stimulated control samples (figure 9(a)). In addition,
IL-1α, IL-6 and IL-8 were also measured in 2D cultures for
comparison with the 3D culture data. Here 2 μM DNCB or
10−4M SDS were added to human keratinocytes, cultured in
12 well plates, for 24 h and the conditioned media removed for
analyses. Furthermore, 2D cultures of dermal fibroblasts were
stimulated with keratinocyte-conditioned media (see above)
for 24 h and the presence of cytokines analysed by ELISA.
No significant increase in IL-1α, IL-6 or IL-8 was observed
when 2 μM DNCB was added to keratinocytes directly or to
fibroblasts indirectly (via the DNCB-stimulated keratinocyte
conditioned medium) (figure 9(b)). However, a significant
increase in IL-1α production was observed when 10−4M SDS
was added to keratinocytes in 2D culture (p = 0.0012) and
a further significant increase in IL-6 was observed when
keratinocyte conditioned medium (containing 10−4M SDS)
was added to fibroblasts (p = 0.0019). No increase in IL-8
was observed under any condition. An explanation of why IL-
1α should vary in the models was investigated in regards to the
age and differentiation of the keratinocytes in culture. Thus,
keratinocytes were either cultured until 80–90% confluence so
that cells were proliferative, or for 3–5 days post confluence
to allow cells to form a multi-layered sample. They were then
incubated with 10−4 M SDS in serum-free DMEM for 24 h,
medium collected and IL-1α measured. When corrected for
total protein it was found that the subconfluent keratinocytes
produced more IL-1α compared to the older multi-layered
sample.
The surface phenotype of mDCs upon stimulation with
DNCB was then investigated. Cells collected from the
supernatant or retrieved from the agarose–fibronectin layer
were examined for lineage marker (CD11c) expression to
ensure that they were of dendritic-cell lineage and also to
minimize inclusion of any gel (or other cellular) debris. The
expression levels of CD86 and HLA-DR on the cells recovered
from the DNCB stimulated models (mDCs-only or complete
three cell type model) after 24 h is summarized in figures 11(A)
and (B), respectively. In addition, the insert in figure 11(A)
compares CD86 expression between a 2D mDCs-only culture
(i.e. on tissue culture plastic and in the presence of fibronectin)
against a 3D mDCs-only culture (i.e. within an agarose–
fibronectin gel). Significant upregulation of CD86 can be seen
to occur in the mDCs (recovered from the complete 3D model)
following stimulation with DNCB compared to the mDCs-only
control samples (p < 0.001). Expression of HLA-DR was also
significantly upregulated (p < 0.001) following stimulation
with DNCB (figure 11(B)).
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Figure 8. mDCs localization within the 3D construct following stimulation with 2 μM DNCB. Live cell fluorescence imaging
(Zeiss LSM510 META confocal microscope) was used to assess the migration of mDCs following 24 h stimulation with 2 μM DNCB
between the different scaffold layers. Images are the representative samples from five random fields of vision with the corresponding cell
populations labelled with different contrasting agents: keratinocytes, Cell Tracker Green and DAPI; mDCs, Cell Tracker Red; fibroblasts,
DAPI-only as described in section 2.
4. Discussion
There is an urgent need for the development of a simple,
cost-effective and physiologically relevant in vitro model
of human skin. Although several models currently exist,
most of them concentrate on a single cell type only
and lack immunocompetency. In this study we describe
the development and initial characterization of a novel
immunocompetent 3D co-culture model. Importantly, the
design of this model is amenable to interactive control and
monitoring of cell migration/activation and ideally suited to
studies of mechanisms of skin sensitization.
The first step in development of the 3D model was seeding
of primary human keratinocytes and dermal fibroblast to a
modified commercially available microfibre-based scaffold.
SEM images showed the presence of ECM and cells covering
and permeating throughout the structural pores of scaffolds
which are characteristic of cell growth and differentiation.
This is in agreement with our previous published work that
demonstrated similar scaffold material is conducive to the
viability and proliferation of keratinocytes and fibroblasts
during culture (Sun et al 2006a, 2005b). In addition, another
important advantage of using such a scaffold is that it
permits raising the cells to an A–L interface, ensuring
correct differentiation and strata formation during the extended
culture period (Poumay and Coquette 2007, Sun et al 2007,
2006a, 2005a, 2005b,). To facilitate construction of the
model we performed pre-treatment of the scaffolds using
acrylic acid plasma polymerization. This process allows a
faster and enhanced attachment of cells without affecting any
biological characteristics (Eves et al 2005, Higham et al 2003,
Haddow et al 1999). Moreover, previous work within our
group has documented that the paracrine signalling between
keratinocytes and fibroblasts plays an important role in the
optimal cell self-organization as well as in response to pro-
inflammatory stimuli (Co`nton et al 2010, Sun et al 2007,
2006b, Smith-Thomas et al 2001). Therefore, to maintain
the stromal-epithelial interdependency inclusion of fibroblasts
into the model was through to be crucial (Werner et al
2007, Nolte et al 2008). These 3D ‘layers’ of keratinocytes
and fibroblasts were then used for the construction of the
immunocompetent model.
mDCs can readily be generated in the laboratory and
have been extensively investigated over the past two decades
(Gluckman et al 1997, Zhou and Tedder 1996, Sallusto and
Lanzavecchia 1994). This includes characterization of their
12
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Figure 9. IL-1α, IL-6 and IL-8 expression in culture models
following direct stimulation with 2 μM DNCB or 10−4M SDS. (A)
Following seven-day culture (A–L interface; at 37 ◦C and 5% (v/v)
CO2), the complete 3D model was stimulated for 24 h with removal
of conditioned medium for analysis by ELISA (n = 4 DNCB; n = 2
SDS), (B) human keratinocytes and fibroblasts cultured separately in
2D. Following seven days in 2D culture, keratinocytes were
stimulated for 24 h with removal of conditioned medium for IL-1α
analysis by ELISA. Keratinocyte-conditioned medium was in turn
added to human dermal fibroblasts in 2D culture for 24 h, with
detection of IL-6 and IL-8 thereafter in conditioned medium by
ELISA (n = 4 DNCB; n = 2 SDS; ∗∗p < 0.01)
responses (mostly in single cell 2D cultures) to chemical
sensitizers and reported to be comparable to those of
Langerhans cells (Tuschl and Kovac 2001, Rustemeyer et al
2003, De Smedt et al 2002). Although other significant
immunological cells exists (e.g. mast cells) (Bischoff 2007)
and correct biological mimicry important, the aim of this
work was to ultimately develop a simple and easy-to-construct
model for drug screening. Thus, for the ‘immune layer’ of
Figure 10. Keratinocyte phenotype is associated with IL-1α release
in response to SDS. Keratinocytes were either cultured until
80–90% confluence so that cells were proliferative, or for 3–5 days
post confluence to allow cells to form a multi-layered more
differentiated sample. Keratinocytes were washed three times with
serum-free DMEM and then incubated with 10−4 M SDS (in
serum-free DMEM) for 24 h (serum-free DMEM was the control).
Following 24 h incubation, medium was collected and IL-1α
measured by ELISA. To determine total protein a BCA protein
assay of the remaining cell lysate was performed and data shown as
pg of IL-1α/μg total sample protein (n = 3).
our 3D model we chose to work with mDCs that were
encapsulated within a permeable agarose–fibronectin gel, and
subsequently sandwiched between keratinocyte and fibroblast
cell layers. The agarose layer provided a convenient means
of incorporating and maintaining a defined number of mDCs
within the 3D model, and equally importantly served as a
platform for delivering a key ECM protein (i.e. fibronectin).
Previous research within our group demonstrated that mDCs
that are cultured in the presence of fibronectin maintain a
more immature phenotype, express higher levels of endocytic
receptors and demonstrate a superior ability to sample the
microenvironment and induce T cell activation (Garcı´a-Nieto
et al 2010). Interestingly, fibronectin has also been extensively
implicated in cell attachment (Pankov and Yamada 2002,
Freedberg et al 2001, Ruoslahti and Pierschbacher 1987,
Hynes and Yamada 1982) and, in particular, associated with
the onset of terminal differentiation in keratinocytes (Clark
et al 1985). Therefore, the presence of fibronectin within the
agarose gel potentially provides several advantages of this
construct over existing models.
To this end, a defined cell number ratio of (5 × 105
keratinocytes, 1.5 × 105 fibroblasts and 3 × 104 mDCs) was
used throughout model development to ensure relevance to an
in vivo environment (Facy et al 2005, Schempp et al 2000).
Characterization of the keratinocyte layer was also performed
by H&E staining as Ki-67 expression is reported to be only
associated with cell proliferation (Scholzen and Gerdes 2000).
Interestingly, differentiation and structural integrity/barrier
formation of the model was significantly enhanced by the
presence of the agarose–fibronectin layer as evidenced by
a more localized, higher and more rapid expression of key
structural proteins such as the collagens, cytokeratins and
involucrin compared with a fibronectin-lacking model. These
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Figure 11. mDCs surface marker expression following stimulation with 2 μM or 10 μM DNCB (direct addition). Following seven-day
culture (A–L interface; at 37 ◦C and 5% (v/v) CO2), the complete 3D model was stimulated with direct addition of 2 μM DNCB for 24 h.
mDCs were then recovered from both the supernatant (sup) and the agarose gel (gel) and analysed using flow cytometry for (A) CD86 and
(B) HLA-DR expression. Absolute MFI value = (MFI sample) – (MFI isotype/unstained sample). mDCs-only 3D samples (i.e.
incorporated within the agarose–fibronectin gel) were used as the control (n = 3; ∗∗p < 0.01).
proteins have been widely reported to be the hallmarks of an
organized and stratified epithelia as well as being involved
in the correct formation of a keratinocyte cornified envelope
(Schweizer et al 2006, Eckert et al 2004). Barrier formation
and integrity was further investigated by measuring the skin
impedance. This data suggested that barrier properties of the
3D model was comparable to tissue-engineered skin and was
also broadly in line with the properties of native skin. Whilst
higher skin impedance measurements are generally indicative
of confluent cell layers with functional tight junctions as well
as formation of a multi-layer stratification (van der Valk et al
2005, 1990, Narai et al 1997), it is also worth pointing out
that the level of impedance signal may be influenced by water
content derived from the presence of the agarose gel, age of the
(donor) samples/cells or, the sampling methodology and/or
location (Johnsen et al 2009, Potts et al 1984). Accordingly
high water content of agarose gel in the 3D skin model could
have contributed to the high impendence readings.
DNCB, a widely used sensitizer, was exploited throughout
this study due to its extensive cell-response documentation in
the literature (Sakaguchi et al 2009, Hooyberghs et al 2008,
Azam et al 2006, Fentem et al 2001). However, an optimal
DNCB concentration was required that not only induced a
response within the 3D model but more importantly did not
infer toxicity on the individual cell populations involved. Using
a combination of cell viability assays (MTT/MTS activity) and
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microscopy, it was found that cells remained viable (>90%)
at DNCB concentration of <3 μM, <10 μM and <50 μM for
the keratinocytes, fibroblasts and mDCs, respectively, within
a 24 h culture period. Therefore, to avoid compromising cell
viability, the 3D model was stimulated with 2 μM of DNCB
in subsequent experiments. To simulate the physiological
condition for chemical exposure the DNCB was added to the
upper keratinocyte layer so that it was able to permeate through
the different strata layers as expected in vivo without being
diluted out in the culture medium or come in contact with other
cell types within the 3D model. Thus, changes in the expression
of key pro-inflammatory cytokines were documented and
compared with the corresponding responses in a 2D single
cell or co-cultures. Interestingly, our data showed that addition
of DNCB or SDS to the upper surface of the 3D model did
not significantly elevate IL-1α, IL-6 or IL-8 levels compared
to control DMSO or un-stimulated cultures (figures 9(A) and
(B)). To explore the difference in response between the 3D
model and cells in 2D culture, we investigated the potential
role of keratinocytes ‘age’ and their differentiation status. This
data demonstrated that keratinocytes (cultured to subconfluent
levels) remained more responsive to stimulation with SDS
compared to heavily confluent multi-layered keratinocytes
(grown 3–5 days post full confluency) (figure 10). As such, the
lack of cytokine response in the 3D model could potentially
be contributed to the differentiated status/phenotype of the
keratinocytes. Intriguingly, our data indicate that stimulation
with 2 μM DNCB leads to a 5–10 fold higher expression of
CD86 and HLA-DR by mDCs within the 3D model compared
to a single culture (in agarose–fibronectin gel) of these cells
and in the absence of keratinocyte and fibroblast layers (p <
0.01) (figures 11(A) and (B)). Whilst the exact mechanism of
such differences in mDCs responses are yet to be elucidated,
they are most likely due to paracrine cross-talk between mDCs,
keratinocytes and fibroblasts.
5. Conclusion
Herein, we describe a novel immunocompetent three-layer
model comprised of a layer of keratinocytes, a layer of
fibroblasts and a central matrix of immune cells (mDCs)
(cultured within an agarose–fibronectin gel). This construct
has been specifically designed to be readily assembled/
disassembled and allows the analyses of the different cell
types localized within the scaffolds, gel or supernatant. We
demonstrate that the model responds to topical application of
a skin sensitizer as evidenced by the up-regulation of CD86 and
HLA-DR on the mDCs. Intriguingly, these same cells produce
a significantly weaker response to DNCB when in isolation.
However, none of the cytokines we examined (i.e. IL-1α, IL-
6 and IL-8) were up-regulated in response to DNCB or SDS
stimulation and is most likely due to more differentiated nature
of keratinocytes, thus leaving the search for an indicative
soluble marker in this model open. We therefore conclude that
the model has potential for research groups interested in the
basic mechanisms of skin sensitization and may also serve as
a foundation for developing future platforms for the allergenic
assessment of chemicals and drugs.
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